Structure Therapeutics GPCR
NASDAQ GPCR
$22.42 +0.41 (+1.86%)
As of: Oct 22, 2026 · 9:49 AM EDT

Structure Therapeutics (GPCR) Other Operating Expenses (2025)

Updated

Structure Therapeutics' Other Operating Expenses came in at -$110.25 million for Q4 2025.

Analysis

Structure Therapeutics (GPCR) Other Operating Expenses (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Structure Therapeutics 4.87 Bn 3.53 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -110.25 Mn
API Access

Structure Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=GPCR&period=max&api_key=YOUR_API_KEY